Evidence map›Paper›PMID 33646178›Full record

ArticleJournal of Parkinson's disease2021

Oral Dysbiosis and Inflammation in Parkinson's Disease.

Vanessa Fleury, Alkisti Zekeridou, Vladimir Lazarevic, Nadia Gaïa, Catherine Giannopoulou, Laurence Genton, José Cancela, Myriam Girard, Rachel Goldstein, Julien F Bally and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 5 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 5 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association between oral dysbiosis and Parkinson's disease: a systematic review.Frontiers in cellular and infection microbiology · 2025
    Pooled it
  4. Pooled it
  5. Oral Microbiota Associated With Parkinson'S Disease: A Systematic Review.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
    Pooled it
  6. ProbioticNutrients · 2022
    Trial
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Exploring the Role of Oral Microbiota in the Pathophysiology and Treatment of Bruxism.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Observational
  19. Oral microbiota and central nervous system diseases: A review.Neuroprotection (Chichester, England) · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Vanessa FleuryFaculty of Medicine, University of Geneva, CMU, Geneva, Switzerland.
Alkisti ZekeridouUniversity Clinic of Dental Medicine, Division of Periodontology, University of Geneva, Geneva, Switzerland.
Vladimir LazarevicGenomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Nadia GaïaGenomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Catherine GiannopoulouUniversity Clinic of Dental Medicine, Division of Periodontology, University of Geneva, Geneva, Switzerland.
Laurence GentonClinical Nutrition, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
José CancelaUniversity Clinic of Dental Medicine, Division of Periodontology, University of Geneva, Geneva, Switzerland.
Myriam GirardGenomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Rachel GoldsteinDivision of Neurology, Geneva University Hospitals, Geneva, Switzerland.
Julien F BallyDivision of Neurology, Geneva University Hospitals, Geneva, Switzerland.
Andrea MombelliUniversity Clinic of Dental Medicine, Division of Periodontology, University of Geneva, Geneva, Switzerland.
Jacques SchrenzelFaculty of Medicine, University of Geneva, CMU, Geneva, Switzerland.
Pierre R BurkhardFaculty of Medicine, University of Geneva, CMU, Geneva, Switzerland.
University of Geneva · CHUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral microbiota has largely escaped attention in Parkinson's disease (PD), despite its pivotal role in maintaining oral and systemic health.

objectiveThe aim of our study was to examine the composition of the oral microbiota and the degree of oral inflammation in PD.

methodsTwenty PD patients were compared to 20 healthy controls. Neurological, periodontal and dental examinations were performed as well as dental scaling and gingival crevicular fluid sampling for cytokines measurement (interleukine (IL)-1β, IL-6, IL-1 receptor antagonist (RA), interferon-γ and tumor necrosis factor (TNF)-α). Two months later, oral microbiota was sampled from saliva and subgingival dental plaque. A 16S rRNA gene amplicon sequencing was used to assess bacterial communities.

resultsPD patients were in the early and mid-stage phases of their disease (Hoehn & Yahr 2-2.5). Dental and periodontal parameters did not differ between groups. The levels of IL-1β and IL-1RA were significantly increased in patients compared to controls with a trend for an increased level of TNF-α in patients. Both saliva and subgingival dental plaque microbiota differed between patients and controls. Streptococcus mutans, Kingella oralis, Actinomyces AFQC_s, Veillonella AFUJ_s, Scardovia, Lactobacillaceae, Negativicutes and Firmicutes were more abundant in patients, whereas Treponema KE332528_s, Lachnospiraceae AM420052_s, and phylum SR1 were less abundant.

conclusionOur findings show that the oral microbiome is altered in early and mid-stage PD. Although PD patients had good dental and periodontal status, local inflammation was already present in the oral cavity. The relationship between oral dysbiosis, inflammation and the pathogenesis of PD requires further study.

Indexed as

Dental PlaqueParkinson DiseaseDysbiosisHumansInflammationInterleukin-1betaKingellaRNA, Ribosomal, 16STumor Necrosis Factor-alphaInterleukin-1betaRNA, Ribosomal, 16STumor Necrosis Factor-alphabiomarkercytokineinflammationmicrobiotanon-motor symptomsOral microbiomeParkinson’s disease

Identifiers

PMID33646178
PMCPMC8150470
OpenAlexW3134303001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.